Rheumatoid Arthritis Diagnostic Tests Market Growth to register a CAGR of 6.9% to reach US$ 3,480.9 Million by 2027, Says Coherent Market Insights

Early diagnosis plays major role in the management of rheumatoid arthritis (RA) as it may lead to other systemic complications and health problems, including heart disease, diabetes, and osteoporosis. Blood tests commonly used to diagnose RA include, rheumatoid factor. anti-cyclic citrullinated peptide, C-Reactive Protein (CRP), and  Erythrocyte Sedimentation Rate (ESR).

Statistics:

The global rheumatoid arthritis diagnostic tests market is estimated to account for US$ 3,480.9 Mn in terms of value by the end of 2027

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/3716

Global Rheumatoid Arthritis Diagnostic Tests Market: Drivers

Development of new blood tests for RA is expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period. For instance, in March 2020, Scipher Medicine developed a blood test PrismRA that can predict non-responses to anti-TNFs such as Humira, Enbrel, Cimzia, Remicade, Simponi, Simponi Aria and Inflectra in patients with RA.

Global Rheumatoid Arthritis Diagnostic Tests Market: Opportunities 

Commercialization of effective and cheaper drugs is expected to offer lucrative growth opportunities for players in the market.  Moreover, it will also help promote the adoption of novel test methods used in the early diagnosis of RA.

Global Rheumatoid Arthritis Diagnostic Tests Market: Restraints 

High cost of novel diagnostic test kits such as Anti–cyclic Citrullinated Peptide (anti–CCP) is expected to hamper growth of the market.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3716

Key Takeaways:

The Serology Test segment of global rheumatoid arthritis diagnostic tests market was valued at US$ 1,631.4 Mn in 2019 and is forecast to reach a value of US$ 2,772.1 Mn by 2027 at a CAGR of 6.9% between 2019 and 2027. Increasing technological advancement in development of new blood tests for RA is expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period.

Diagnostic Laboratories segment held dominant position in the global rheumatoid arthritis diagnostic tests market in 2019, accounting for 41.5% share in terms of value, followed by hospitals segment, respectively. Increasing prevalence of RA is expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period.

Market Trends

Limited specificity of diagnostic tests available for RA trigger the need for combined diagnosis, which includes multiple tests such as RF and ANA test. The trend of diagnosing RA through multiple tests is gaining popularity.

RA is highly prevalent across the working population aged 18–40 in North America and Europe. Hence, demand for RA test kits is high in the counties with large working population. Presently, there is no effective medication available for RA, which is responsible for the high consumption of off label drugs in the concerned regions.

Global Rheumatoid Arthritis Diagnostic Tests Market: Competitive Landscape

Major players operating in the global rheumatoid arthritis diagnostic tests market include Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.

Global Rheumatoid Arthritis Diagnostic Tests Market: Key Developments

Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in March 2020, Exagen Diagnostics, Inc. entered into a strategic partnership with Sonora Quest, an integrated laboratory system. The agreement provides preferred access through Sonora Quest Laboratories in Arizona to Exagen’s AVISE testing for differential diagnosis of complex and incurable autoimmune rheumatic diseases.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/rheumatoid-arthritis-diagnostic-tests-market-3013

Segmentation

Scope of the report

• Rheumatoid Arthritis Diagnostic Tests Market, By Test Type:
  • Serology Test
    • Erythrocyte Sedimentation Rate (ESR)
    • Rheumatoid Factor (RF)
    • Anti-cyclic Citrullinated Peptide (anti-CCP)
    • Antinuclear Antibody (ANA)
    • Uric Acid
    • Other Tests
  • Monitoring RA Treatment Efficiency Tests
    • Salicylate Level Count
    • Muscle Enzyme Tests (CPK, Aldolase)
    • Creatinine Test
• Rheumatoid Arthritis Diagnostic Tests Market, By End User:
  • Diagnostic Laboratories
  • Private Laboratories
  • Public Laboratories
  • Ambulatory Surgical Centers
• Rheumatoid Arthritis Diagnostic Tests Market, By Region:
  • North America
    • By Test Type:
      • Serology Test
        • Erythrocyte Sedimentation Rate (ESR)
        • Rheumatoid Factor (RF)
        • Anti-cyclic Citrullinated Peptide (anti-CCP)
        • Antinuclear Antibody (ANA)
        • Uric Acid
        • Other Tests
      • Monitoring RA Treatment Efficiency Tests
        • Salicylate Level Count
        • Muscle Enzyme Tests (CPK, Aldolase)
        • Creatinine Test
    • By End-User
      • Diagnostic Laboratories
      • Private Laboratories
      • Public Laboratories
      • Ambulatory Surgical Centers
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Test Type:
    • By End-User
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Test Type:
    • By End-User
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Test Type:
    • By End-User
    • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Test Type:
    • By End-User
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Test Type:
    • By End-User
    • By Country:
      • South Africa
      • Central Africa
      • North Africa

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837